Q32 Bio

Public

Waltham, MassachusettsHealthcarehttps://www.q32bio.com

Q32 Bio is now publicly traded

The data on this page reflects Q32 Bio's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Mar 25, 2024

Total Funding Raised

$148M

Company Overview

Q32 Bio (NAS: QTTB) is a biotechnology company focused on developing innovative biologics to restore immune balance in patients with autoimmune and inflammatory diseases through antibody-based therapeutics.

Sector

Healthcare

AI Layer

Non-AI

Keywords

tissue-targeted complement inhibitorfully human anti-IL-7Rα antibodybiologic therapeutics for autoimmune diseasesIL-7 and TSLP pathway blockertherapeutics for complement-mediated diseasesalopecia areata biologic therapeuticadaptive immune system regulationclinical-stage biotechnology companytherapeutics for inflammatory renal diseasesimmune homeostasis restoration

Q32 Bio Comparables

Compare Q32 Bio with similar companies based on industry and business-model similarity.

Q32 Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Attovia Therapeutics	61%
Linno Pharmaceuticals Inc.	60%

View all Comparables

Q32 Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Mar 25, 2024
Series B	Oct 29, 2020
Series A	May 27, 2020

View all Funding Rounds

Q32 Bio Investors

Notable investors and investment history

Q32 Bio investors
Investor	Rounds
Agent Capital	Private Placement
Osage University Partners	Series B, Private Placement
OrbiMed	Series A, Private Placement, Series B
Accomplice	Series B, Private Placement, Series A
Acorn Bioventures	Private Placement, Series B
Abingworth	Series A, Series B, Private Placement
Sanofi Ventures	Series A, Series B, Private Placement

View all Investors

Q32 Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Q32 Bio Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersWaltham, Massachusetts

Employee Range26

Year Founded2018

Last FundingMar 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?